О себе
Michael Curtis is a European private credit executive with a background in leveraged loans, high-yield bonds, structured credit, and CLOs. He was appointed Chief Investment Officer of MeDirect in 2018 after prior investing roles at ICG, 3i Debt Management, and Alpstar Capital. Earlier in his career, he worked in leveraged finance and restructuring at CIBC World Markets and holds a BSc in Economics from University College London.
Области интересов
biotechxenotransplantationgenome engineeringorgan transplantationkidney diseaseliver diseaseneurosciencerare diseaseoncology